CareTrust REIT, Inc. — Form 8-K Summary
Business context and timing: The filing, dated October 2, 2026, reports a UK care-home transaction under a share purchase deed dated September 30. CareTrust, through CareTrust UK Limited, completed its acquisition of companies holding 23 completed care homes on October 1, with one additional completed home still subject to regulatory approval.
Transaction and financial details
- The company intends to acquire companies holding up to 21 additional care homes currently under development, subject to put and call options, development completion and regulatory approvals. Closings are anticipated on a rolling basis through December 31, 2027.
- The stated price is £24 million per property: approximately £576 million (about $764 million) for the 24 completed properties and approximately £504 million (about $669 million) for the 21 in-development properties. These amounts exclude transaction costs.
- The properties are or are expected to be leased to Crystal Care Holdco subsidiaries under triple-net leases with fixed annual escalators and renewal options. LNT guarantees the lease payment obligations.
- After an initial lease-up phase, and subject to applicable options, the Operating Partnership or an affiliate expects to acquire the operating companies and transition the homes to a SHOP structure. The operating-company purchase price will be based on a specified multiple of implied annualized mature EBITDA, subject to adjustments.
- LNT shareholders also granted the Operating Partnership an option, exercisable through September 2027, to acquire all of LNT’s issued share capital.
Other financial information and comparison
This transaction-focused 8-K does not provide revenue, profit, cash flow, margin, debt, liquidity, yield or accretion figures, nor a clear value for the operating-company purchase prices. It does not provide a comparable prior-period financial performance measure or updated company-wide guidance.
Outlook, contingencies and risks
- Completion of the in-development acquisitions depends on development progress, practical completion, regulatory registration and other closing conditions; timing or completion is not assured.
- Management’s expected lease-up, stabilization, net operating income yields and accretion may not be achieved. The operating-company options may not be exercised, and the SHOP Transition may be delayed or not occur.
- The company identifies potential changes in UK regulation, reimbursement, labor and tax environments, as well as the possibility that the transaction’s intended benefits are not realized.
- The filing states that its forward-looking statements are subject to risks described in the company’s 2025 Form 10-K and June 30, 2026 Form 10-Q.
Important facts for investors to verify
- Regulatory approval and closing status of the 24th completed home and the remaining 21 developments.
- Actual transaction costs, funding sources and effects on CareTrust’s debt and liquidity.
- Lease commencement, lease-up performance, rent collections and realized yields or accretion.
- Exercise of the operating-company and LNT options, and timing and terms of any SHOP Transition.
- The purchase agreement and transaction details in Exhibits 2.1 and 99.2; the filing references additional investor materials and management remarks.